Skip to content

Relationship Between Lower Body Muscle Mass and Dizziness in Diabetes:A Study on Blood Pressure Changes with Postural Shifts

Evaluation and investigation of orthostatic hypotension in Type 2 diabetes in terms of lower limb muscle mass: Comparative study of blood pressure variability associated with positional changes - Evaluation and investigation of orthostatic hypotension in Type 2 diabetes in terms of lower limb muscle mass: Comparative study of blood pressure variability associated with positional changes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000057177
Enrollment
120
Registered
2025-04-01
Start date
2023-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes and healthy subjects

Interventions

None listed

Sponsors

Nagoya university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Common: (1) Those who are independent in their daily lives. (2) Those who are able to quit smoking and drinking on the day of the standing test. (3) Those who are hungry or have eaten for at least 2 hours prior to the test. Subjects: Type 2 diabetics: Patients who are hospitalized for glycemic control, scheduled retinopathy surgery, or diabetes education. Healthy subjects: (1) Those who do not have specific chronic diseases (diabetes, heart disease, chronic obstructive pulmonary disease, chronic kidney disease, Parkinson's disease, etc.) and have no difficulty in daily living (2) Those who have had or will have a hemoglobin A1c (HbA1c: 4.0~6.4%) blood test within 2 months before or after the day they wish to participate in the study or are scheduled to take the test.

Exclusion criteria

Exclusion criteria: (i) Patients with type 2 diabetes mellitus 2) Patients who use the following drugs (drugs that affect the autonomic nervous system, tranquilizers, psychostimulants, levodopa and other drugs for the treatment of Parkinson's disease, vasodilators, etc.) Persons who have exercised in a way that causes heavy exhalation on the day of the examination. Subjects who wear a pacemaker. Persons who are deemed inappropriate as research subjects by the principal investigator. (2) Normal subjects: Persons using the following drugs (drugs that affect the autonomic nervous system, tranquilizers, psychostimulants, levodopa and other drugs for the treatment of Parkinson's disease, vasodilators, hypertension, etc.) Persons with the following chronic diseases (heart disease, chronic obstructive pulmonary disease, chronic kidney disease, Parkinson's disease, etc.) Persons who have exercised on the day of the examination in a way that causes heavy exhalation. Persons who wear a pacemaker. Persons who are deemed inappropriate as research subjects by the principal investigator.

Design outcomes

Primary

MeasureTime frame
Comparison of changes in blood pressure and lower limb muscle mass during standing at admission, at discharge, and around 3 months after discharge Comparison of blood pressure changes during standing and other changes in healthy subjects and type 2 diabetes mellitus

Secondary

MeasureTime frame
Change in HbA1c at admission and around 3 months after discharge Comparison of diabetic lifestyle questionnaires at admission and around 3 months after discharge Comparison of subjective symptoms of orthostatic hypotension at admission, at discharge, and around 3 months after discharge Cardiac output, heart rate, R-R interval

Countries

Japan

Contacts

Public ContactQINGBO ZHANG

Nagoya University Department of Nursing, Graduate School of Medicine

zhang.qingbo.r9@s.mail.nagoya-u.ac.jp052-719-1518

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026